Viromed Medical AG Expands with New Distribution Partnerships

Viromed Medical AG, a leader in cold plasma technology, has announced new distribution agreements for its ViroCAP® product in six additional markets: Spain, Portugal, Greece, the Balkans, Romania, and Saudi Arabia. These partnerships mark a significant expansion of Viromed's international presence, with separate agreements tailored to each market. Each contract includes minimum purchase commitments, with Viromed aiming to sell at least 3,000 devices annually through these new collaborations.

ViroCAP® is a mobile device that uses cold atmospheric plasma to treat skin conditions and targets healthcare professionals and facilities. CEO Uwe Perbandt highlighted the promising market opportunities in Southern Europe and the Middle East, reflecting strong demand for Viromed's technology. He further noted that additional agreements are expected in the coming weeks, underscoring the company's commitment to growth.

Viromed already has existing distribution agreements, including an exclusive deal with Korea’s UMECO and a partnership for the Turkish market, showcasing a robust global strategy.